Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)
Turkey
· Delayed Price · Currency is TRY 286.50
+5.50 (1.96%)
At close: Dec 5, 2025
IST:ONCSM Cash Flow Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 32.46 | -59.17 | -115.23 | -20.76 | 71.73 |
| Depreciation & Amortization | 36.74 | 48.1 | 52.94 | 36.45 | 8 |
| Other Amortization | 6.69 | 4.11 | 3.44 | 2.86 | - |
| Loss (Gain) From Sale of Assets | -0.34 | 0.03 | - | - | - |
| Provision & Write-off of Bad Debts | -0.14 | - | 15.79 | 2.24 | 0.56 |
| Other Operating Activities | 29.88 | 67.9 | 30.11 | -11.12 | 8.73 |
| Change in Accounts Receivable | -59.6 | -7.1 | 0.62 | 21.17 | -13.09 |
| Change in Inventory | 6.5 | 28.77 | 15.13 | 6.97 | -27.96 |
| Change in Accounts Payable | 14.78 | -11.08 | -12.86 | -3.86 | 4.65 |
| Change in Other Net Operating Assets | -11.6 | 14.1 | -26.87 | 18.75 | -0.89 |
| Operating Cash Flow | 55.37 | 85.66 | -36.92 | 52.69 | 51.73 |
| Operating Cash Flow Growth | -27.64% | - | - | 1.86% | - |
| Capital Expenditures | -16.95 | - | - | -26.02 | -10.96 |
| Cash Acquisitions | - | - | - | - | -24.35 |
| Sale (Purchase) of Intangibles | -2.32 | - | - | - | -1.68 |
| Investment in Securities | -5.6 | -0.74 | -1.16 | -1.05 | - |
| Other Investing Activities | -23.47 | -23.47 | -30.51 | - | -0.8 |
| Investing Cash Flow | -48.1 | -24.21 | -31.67 | -27.07 | -37.79 |
| Long-Term Debt Issued | - | - | 59.32 | - | 0.35 |
| Short-Term Debt Repaid | - | - | - | - | -5.95 |
| Long-Term Debt Repaid | - | -42.61 | -1.92 | -12.79 | -8.68 |
| Total Debt Repaid | -15.24 | -42.61 | -1.92 | -12.79 | -14.64 |
| Net Debt Issued (Repaid) | -3.62 | -42.61 | 57.4 | -12.79 | -14.29 |
| Issuance of Common Stock | - | - | 147.28 | - | - |
| Common Dividends Paid | - | - | -19.91 | - | - |
| Other Financing Activities | -20.34 | -34.62 | -13.83 | -1.47 | -2.31 |
| Financing Cash Flow | -23.96 | -77.23 | 170.94 | -14.26 | -16.59 |
| Miscellaneous Cash Flow Adjustments | -7.73 | -24.08 | -45.62 | -7.73 | - |
| Net Cash Flow | -24.42 | -39.86 | 56.73 | 3.63 | -2.65 |
| Free Cash Flow | 38.41 | 85.66 | -36.92 | 26.67 | 40.76 |
| Free Cash Flow Growth | -49.51% | - | - | -34.58% | - |
| Free Cash Flow Margin | 7.28% | 22.87% | -10.63% | 9.10% | 31.85% |
| Free Cash Flow Per Share | 1.61 | 3.59 | -1.55 | 2.20 | 172.23 |
| Cash Interest Paid | 20.34 | 34.62 | 13.83 | 1.47 | 2.31 |
| Cash Income Tax Paid | 1.57 | -0.36 | 4 | 5 | -4.65 |
| Levered Free Cash Flow | -40.9 | 49.13 | -57.89 | -25.2 | - |
| Unlevered Free Cash Flow | -28.18 | 70.91 | -48.99 | -23.93 | - |
| Change in Working Capital | -49.92 | 24.69 | -23.98 | 43.02 | -37.3 |
Source: S&P Capital IQ. Standard template. Financial Sources.